Eastman Chemical (EMN) Tops Q4 EPS by 26c; offers guidance
Tweet
Share
E-mail
Get Alerts EMN Hot Sheet
Price: $71.19 --0%
Revenue Growth %: +10.0%
Financial Fact:
Cost of sales: 1.67B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +10.0%
Financial Fact:
Cost of sales: 1.67B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.87, $0.26 better than the analyst estimate of $1.61. Revenue for the quarter came in at $2.25 billion versus the consensus estimate of $2.28 billion.
GUIDANCE:
Eastman Chemical sees FY2025 EPS of $8.00-$8.75, versus the consensus of $8.46.
For earnings history and earnings-related data on Eastman Chemical (EMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- StoneX Reiterates Buy Rating on DraftKings Inc. (DKNG)
- StoneX Reiterates Buy Rating on Prenetics (PRE)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
